NO972963L - Flerfaset mykgelatin-doseringsform - Google Patents

Flerfaset mykgelatin-doseringsform

Info

Publication number
NO972963L
NO972963L NO972963A NO972963A NO972963L NO 972963 L NO972963 L NO 972963L NO 972963 A NO972963 A NO 972963A NO 972963 A NO972963 A NO 972963A NO 972963 L NO972963 L NO 972963L
Authority
NO
Norway
Prior art keywords
dosage form
soft gelatin
gelatin dosage
multiphase
multiphase soft
Prior art date
Application number
NO972963A
Other languages
English (en)
Norwegian (no)
Other versions
NO972963D0 (no
Inventor
Michael R Hoy
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of NO972963D0 publication Critical patent/NO972963D0/no
Publication of NO972963L publication Critical patent/NO972963L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO972963A 1996-06-28 1997-06-25 Flerfaset mykgelatin-doseringsform NO972963L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/671,979 US6024980A (en) 1996-06-28 1996-06-28 Multiphase soft gelatin dosage form

Publications (2)

Publication Number Publication Date
NO972963D0 NO972963D0 (no) 1997-06-25
NO972963L true NO972963L (no) 1997-12-29

Family

ID=24696660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972963A NO972963L (no) 1996-06-28 1997-06-25 Flerfaset mykgelatin-doseringsform

Country Status (24)

Country Link
US (1) US6024980A (de)
EP (1) EP0815855B1 (de)
JP (1) JPH10182437A (de)
KR (1) KR980000438A (de)
CN (1) CN1172642A (de)
AR (1) AR007648A1 (de)
AT (1) ATE223707T1 (de)
AU (1) AU2620197A (de)
BR (1) BR9703771A (de)
CO (1) CO4900025A1 (de)
CZ (1) CZ205697A3 (de)
DE (1) DE69715319T2 (de)
DK (1) DK0815855T3 (de)
ES (1) ES2183089T3 (de)
HU (1) HUP9701113A2 (de)
ID (1) ID17794A (de)
IL (1) IL121145A0 (de)
NO (1) NO972963L (de)
NZ (1) NZ328182A (de)
PL (1) PL320815A1 (de)
PT (1) PT815855E (de)
SG (1) SG54525A1 (de)
TN (1) TNSN97111A1 (de)
ZA (1) ZA975767B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US7763276B1 (en) 1999-02-26 2010-07-27 Shionogi & Co., Ltd. Chewable soft capsules having improved administration properties and process for producing the same
US20030060422A1 (en) 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
WO2003024421A2 (en) * 2001-09-18 2003-03-27 The North West University Triclosan dosage form
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US20050020613A1 (en) * 2002-09-20 2005-01-27 Alpharma, Inc. Sustained release opioid formulations and method of use
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US20050249802A1 (en) * 2004-05-06 2005-11-10 The Procter & Gamble Company Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
AU2010300641B2 (en) * 2009-09-30 2016-03-17 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
US20130280323A1 (en) * 2012-04-13 2013-10-24 Banner Pharmacaps, Inc. Soft Elastic Capsules Containing Tablets and Liquid or Semisolid Fills and Methods for Their Manufacture
MX366159B (es) 2012-11-30 2019-07-01 Acura Pharmaceuticals Inc Liberacion autorregulada de ingrediente farmaceutico activo.
ES2619121T3 (es) * 2013-03-15 2017-06-23 Warner Chilcott Company, Llc Forma farmacéutica de dosificación en cápsula de gelatina blanda con goma guar modificada
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015145461A1 (en) 2014-03-26 2015-10-01 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
BR112020016884A2 (pt) * 2018-02-26 2020-12-15 R.P. Scherer Technologies, Llc Forma de dosagem farmacêutica para uma emulsão de simeticona e loperamida
SG11202101309WA (en) * 2018-08-31 2021-03-30 Arctic Therapeutics Llc Novel topical formulation for intradermal application and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59131355A (ja) * 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
EP0211079A4 (de) * 1985-01-31 1988-02-15 Fujisawa Pharmaceutical Co Biegsame kapsel mit mehreren kammern, verfahren und vorrichtung für deren herstellung.
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4639846A (en) * 1985-08-16 1987-01-27 Bbc Brown, Boveri & Company, Limited Method and compensating device for compensating current oscillations
US5209978A (en) * 1985-12-26 1993-05-11 Taisho Pharmaceutical Co., Ltd. Seamless soft capsule and production thereof
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
DE3727894A1 (de) * 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US5073384A (en) * 1989-10-19 1991-12-17 Valentine Enterprises, Inc. Maltodextrin/defoaming composition combinate
GB8926612D0 (en) * 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
CA2165789A1 (en) * 1993-06-30 1995-01-12 Takehisa Hata Encapsulated medicine
US5725846A (en) * 1995-03-02 1998-03-10 The Gillette Company Clear antiperspirant stick containing dibenzylidene alditol and hydroxyalkyl cellulose

Also Published As

Publication number Publication date
PL320815A1 (en) 1998-01-05
HUP9701113A2 (hu) 1998-08-28
ATE223707T1 (de) 2002-09-15
HU9701113D0 (en) 1997-08-28
DE69715319T2 (de) 2003-01-23
EP0815855A1 (de) 1998-01-07
CZ205697A3 (cs) 1998-01-14
DE69715319D1 (de) 2002-10-17
ZA975767B (en) 1998-12-28
US6024980A (en) 2000-02-15
AU2620197A (en) 1998-01-15
SG54525A1 (en) 1998-11-16
NO972963D0 (no) 1997-06-25
NZ328182A (en) 1998-11-25
KR980000438A (ko) 1998-03-30
PT815855E (pt) 2003-01-31
MX9704846A (es) 1998-07-31
JPH10182437A (ja) 1998-07-07
ID17794A (id) 1998-01-29
ES2183089T3 (es) 2003-03-16
IL121145A0 (en) 1997-11-20
DK0815855T3 (da) 2003-01-06
BR9703771A (pt) 1998-09-01
CO4900025A1 (es) 2000-03-27
EP0815855B1 (de) 2002-09-11
CN1172642A (zh) 1998-02-11
TNSN97111A1 (fr) 2005-03-15
AR007648A1 (es) 1999-11-10

Similar Documents

Publication Publication Date Title
NO972963L (no) Flerfaset mykgelatin-doseringsform
EP0684044A3 (de) Ein Dendrimer und Wirkstoff enthaltende Zusammensetzung.
MA26568A1 (fr) Association d'un inhibiteur d'aldose-reductase et d'un inhibiteur de glycogene-phosphorylase et composition pharmaceutique la contenant
FR2624874B1 (fr) Composition gelifiable a base d'organosiloxanes, gel produit a partir de cette composition, et pansement et prothese contenant ce gel
FI964583L (fi) Tokoferolikoostumuksia biologisesti aktiivisten aineiden antamiseksi
DE69811054D1 (de) Verpackung von folienartigen pflaster
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
FR2563711B1 (fr) Ensemble pour le conditionnement et l'application d'une substance, notamment cosmetique, se presentant sous la forme solide
FI873200A7 (fi) Faasimuutosmateriaalia sisältäviä polyetyleenikomposiittejä.
ATE268167T1 (de) Mehrphasige wirkstoffhaltige zubereitungsformen
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
FR2733239B1 (fr) Compositions de film polymere de revetement et compositions de materiau d'enregistrement stabilisees
MA26502A1 (fr) Analogues peptidiques de la lh-rh, leur utilisation et les compositions pharmaceutiques les contenant.
MX164826B (es) Composicion de cloruro de vinilideno y pelicula hecha a partir de la misma
NO973014D0 (no) Fyllmateriale for farmasöytisk mykgelatin-doseringsform
FR2473884B1 (fr) Associations d'une halogeno-propiophenone et d'une diazepine, medicaments tranquillisants contenant de telles associations, et leur preparation
EP0809509A4 (de) Allosterische regulation von nukleären hormonrezeptoren
HUP9603302A2 (en) Biaromatic compounds bearing a 4-adamantyl-phenyl group, pharmaceutical and cosmetic compositions containing them and use of the cosmetic compositions
FR2730995B1 (fr) Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
BR9810285A (pt) Solução, composição farmacêutica, e, cápsula de gelatina.
ZA968230B (en) Administration of biologically active material
FR2756735B1 (fr) Agent d'inhibition de l'expression de la proteine d'adherence icam-1 et compositions cosmetiques et pharmaceutiques le contenant
FR2714603B1 (fr) Composition dermatologique et son utilisation pour la préparation d'un médicament.
FR2770109B1 (fr) Applicateur d'une substance, notamment d'une matiere deodorante
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application